Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: Clin Immunol. 2020 Jan 8;211:108342. doi: 10.1016/j.clim.2020.108342

Table 5.

Associations Between Disease Duration and Cytokine Expression After Activation of PBMCs With Immunostimulants

Association

Time Stimulant Positive Negative

Visit 1 CD3/CD28 IL-5**
PHA
PMA/Ion Factor 1**, factor 3***, IL-10**, IL-12**, IL-6***, IL-17***, GM-CSF**, IL-4**,IL-5**, MIP-1β***a
SEA/SEB Factor 1*, IL-5***, IL-17*, GM-CSF*, MCP-1*a
CpG IL-12*a, IL-8*a Factor 1*, G-CSF**, IL-1β*, MIP-1β*, IL-17**a
Medium Factor 1**, factor 3***, G-CSF**, IFN-γ*, IL-1β**, IL-5***, TNF-α**, IL-6***, IL-17***, GM-CSF*, MCP-1*, IL-2*a, IL-10**a
Change between visits CD3/CD28 IL-5**, GM-CSF**
PHA IL-17*
PMA/Ion Factor 1**, factor 3**, IL-10*, IL-6***, IL-17***, GM-CSF***, IFN-γ*a, MIP-1β**a,IL-4**
SEA/SEB Factor 1***, factor 2**, IL-1β**, IL-17*, TNF-α**, IL-5*, GM- CSF***, MIP-1β*, IFN-Y**a, MCP-1*a
CpG Factor 1**, G-CSF*, MIP-1β*, IL-17*a
Medium Factor 1*, G-CSF*, IL-1β***, IL-5*, TNF-α*, IL-6***, IL-17***, GM-CSF*, MCP-1**, MIP-1β***, IL-10*a
Visit 2 CD3/CD28 GM-CSF*
PHA IFN-γ**, IL-13*
PMA/Ion IL-6***, GM-CSF*, MIP-1β*a
SEA/SEB Factor 1*, factor 2**, IL-1β**, GM-CSF***, LFN-γ***a
CpG Factor 1* IFN-γ***, IL-5*
Medium IL-1β*, IL-6**, IL-17*, GM-CSF**, MIP-1β** Factor 2*

Abbreviations: CD3/CD28, anti-CD3 and anti-CD28 microbeads; CpG, cytosine-phosphate-guanine oligonucleotide ODN2006; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin; MCP, monocyte chemoattractant protein; Medium, RPMI 1640 medium with 10% fetal calf serum; MIP, macrophage inflammatory protein; PBMC, peripheral blood mononuclear cell; PHA, phytohemagglutinin; PMA/Ion, phorbol 12-myristate 13-acetate–ionomycin; SEA/SEB, staphylococcal enterotoxins A and B; TNF, tumor necrosis factor.

a

Cytokine that was not loaded into a factor at 0.5 or more.

*

P<.05.

**

P≤.01.

***

P≤.001.